| 1 |
SAVANI R C. Modulators of inflammation in bronchopulmonary dysplasia［J］. Semin Perinatol， 2018， 42（7）： 459-470.
|
| 2 |
BERKELHAMER S K， MESTAN K K， STEINHORN R. An update on the diagnosis and management of bronchopulmonary dysplasia （BPD）-associated pulmonary hypertension［J］. Semin Perinatol， 2018， 42（7）： 432-443.
|
| 3 |
IBRAHIM J， BHANDARI V. The definition of bronchopulmonary dysplasia： an evolving dilemma［J］. Pediatr Res， 2018， 84（5）： 586-588.
|
| 4 |
HWANG J S， REHAN V K. Recent advances in bronchopulmonary dysplasia： pathophysiology， prevention， and treatment［J］. Lung， 2018， 196（2）： 129-138.
|
| 5 |
PARKER R A， LINDSTROM D P， COTTON R B. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia［J］. Semin Perinatol， 1996， 20（3）： 206-209.
|
| 6 |
RONKAINEN E， PERHOMAA M， MATTILA L，et al.Structural pulmonary abnormalities still evident in schoolchildren with new bronchopulmonary dysplasia［J］. Neonatology， 2018， 113（2）： 122-130.
|
| 7 |
KATO M， NATARAJAN R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory［J］. Nat Rev Nephrol， 2019， 15（6）： 327-345.
|
| 8 |
WU R， WANG L， YIN R， et al. Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory-driven colon cancer［J］. Mol Carcinog， 2020， 59（2）： 227-236.
|
| 9 |
CASTRO-SANTOS P， DÍAZ-PEÑA R. Genomics and epigenomics in rheumatic diseases： what do they provide in terms of diagnosis and disease management？［J］. Clin Rheumatol， 2017， 36（9）： 1935-1947.
|
| 10 |
AGUDELO GARCIA P A， HOOVER M E， ZHANG P，et al. Identification of multiple roles for histone acetyltransferase 1 in replication-coupled chromatin assembly［J］. Nucleic Acids Res， 2017， 45（16）： 9319-9335.
|
| 11 |
MAHMOUD A M， ALI M M. Methyl donor micronutrients that modify DNA methylation and cancer outcome［J］. Nutrients，2019，11（3）：608.
|
| 12 |
YANG X W， WONG M P M， NG R K. Aberrant DNA methylation in acute myeloid leukemia and its clinical implications［J］. Int J Mol Sci， 2019， 20（18）： 4576.
|
| 13 |
GINDER G D， WILLIAMS D C. Readers of DNA methylation， the MBD family as potential therapeutic targets［J］. Pharmacol Ther， 2018， 184： 98-111.
|
| 14 |
ZHU Y， FU J， YANG H， et al. Hyperoxia-induced methylation decreases RUNX3 in a newborn rat model of bronchopulmonary dysplasia［J］. Respir Res， 2015， 16： 75.
|
| 15 |
CUNA A， HALLORAN B， FAYE-PETERSEN O， et al. Alterations in gene expression and DNA methylation during murine and human lung alveolar septation［J］. Am J Respir Cell Mol Biol， 2015， 53（1）： 60-73.
|
| 16 |
ZHU L， LI H， TANG J， et al. Hyperoxia arrests alveolar development through suppression of histone deacetylases in neonatal rats［J］. Pediatr Pulmonol， 2012， 47（3）： 264-274.
|
| 17 |
ROBBINS M E， DAKHLALLAH D， MARSH C B， et al. Of mice and men： correlations between microRNA-17－92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia［J］. Am J Physiol Lung Cell Mol Physiol， 2016， 311（5）： L981-L984.
|
| 18 |
CHEN C M， LIU Y C， CHEN Y J， et al. Genome-wide analysis of DNA methylation in hyperoxia-exposed newborn rat lung［J］. Lung， 2017， 195（5）： 661-669.
|
| 19 |
BIK-MULTANOWSKI M， REVHAUG C， GRABOWSKA A， et al. Hyperoxia induces epigenetic changes in newborn mice lungs［J］. Free Radic Biol Med， 2018， 121： 51-56.
|
| 20 |
REVHAUG C， BIK-MULTANOWSKI M， ZASADA M，et al. Immune system regulation affected by a murine experimental model of bronchopulmonary dysplasia： genomic and epigenetic findings［J］. Neonatology， 2019， 116（3）： 269-277.
|
| 21 |
CHENG H R， HE S R， WU B Q， et al. Deep Illumina sequencing reveals differential expression of long non-coding RNAs in hyperoxia induced bronchopulmonary dysplasia in a rat model［J］. Am J Transl Res， 2017， 9（12）： 5696-5707.
|
| 22 |
SIDOLI S， TREFELY S， GARCIA B A， et al. Integrated analysis of acetyl-CoA and histone modification via mass spectrometry to investigate metabolically driven acetylation［J］. Methods Mol Biol， 2019， 1928： 125-147.
|
| 23 |
KIM J E. Bookmarking by histone methylation ensures chromosomal integrity during mitosis［J］. Arch Pharm Res， 2019， 42（6）： 466-480.
|
| 24 |
LIN Y M， LI Y， ZHU X T，et al.Genetic contexts characterize dynamic histone modification patterns among cell types［J］.Interdiscip Sci， 2019， 11（4）：698-710.
|
| 25 |
ORENAY-BOYACIOGLU S， KASAP E， GERCEKER E， et al. Expression profiles of histone modification genes in gastric cancer progression［J］. Mol Biol Rep， 2018， 45（6）： 2275-2282.
|
| 26 |
DASKALAKI M G， TSATSANIS C， KAMPRANIS S C. Histone methylation and acetylation in macrophages as a mechanism for regulation of inflammatory responses［J］. J Cell Physiol， 2018， 233（9）： 6495-6507.
|
| 27 |
CHAO C M， BRUCK RVAN DEN， LORK S， et al. Neonatal exposure to hyperoxia leads to persistent disturbances in pulmonary histone signatures associated with NOS3 and STAT3 in a mouse model［J］. Clin Epigenetics， 2018， 10： 37.
|
| 28 |
COHEN J， JVAN MARTER L， SUN Y， et al. Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia［J］. Genome Biol， 2007， 8（10）： R210.
|
| 29 |
LONDHE V A， SUNDAR I K， LOPEZ B， et al. Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung［J］. Pediatr Res， 2011， 69（5 Pt 1）： 371-377.
|
| 30 |
NI W， LIN N， HE H， et al. Lipopolysaccharide induces up-regulation of TGF-α through HDAC2 in a rat model of bronchopulmonary dysplasia［J］. PLoS One， 2014， 9（3）： e91083.
|
| 31 |
MODY K， SASLOW J G， KATHIRAVAN S， et al. Sirtuin1 in tracheal aspirate leukocytes： possible role in the development of bronchopulmonary dysplasia in premature infants［J］. J Matern Fetal Neonatal Med， 2012， 25（8）： 1483-1487.
|
| 32 |
MENDEN H， XIA S， MABRY S M， et al. Histone deacetylase 6 regulates endothelial MyD88-dependent canonical TLR signaling， lung inflammation， and alveolar remodeling in the developing lung［J］. Am J Physiol Lung Cell Mol Physiol， 2019， 317（3）： L332-L346.
|
| 33 |
YU X H， WANG H F， WU J B， et al. Non-coding RNAs derailed： The many influences on the fatty acid reprogramming of cancer［J］. Life Sci， 2019， 231： 116509.
|
| 34 |
PANIR K， SCHJENKEN J E， ROBERTSON S A，et al.Non-coding RNAs in endometriosis： a narrative review［J］. Hum Reprod Update， 2018，24（4）： 497-515.
|
| 35 |
LU T X， ROTHENBERG M E. MicroRNA［J］. J Allergy Clin Immunol， 2018， 141（4）： 1202-1207.
|
| 36 |
PIEDADE D， AZEVEDO-PEREIRA J M. MicroRNAs as important players in host-adenovirus interactions［J］. Front Microbiol， 2017， 8： 1324.
|
| 37 |
DURRANI-KOLARIK S， POOL C A， GRAY A， et al. miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia［J］. Am J Physiol Lung Cell Mol Physiol， 2017， 313（2）： L339-L349.
|
| 38 |
AMEIS D， KHOSHGOO N， IWASIOW B M， et al. MicroRNAs in lung development and disease［J］. Paediatr Respir Rev， 2017， 22： 38-43.
|
| 39 |
XING Y， FU J， YANG H， et al. MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia［J］. Int J Mol Med， 2015， 36（5）： 1253-1263.
|
| 40 |
LAL C V， OLAVE N， TRAVERS C， et al. Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants［J］. JCI Insight，2018，3（5）：e93994.
|
| 41 |
SUN Y F， MA L， GONG X H， et al. Expression of microRNA-495-5p in preterm infants with bronchopulmonary dysplasia：a bioinformatics analysis［J］.Chin J Contemp Pediatr，2020，22（1）： 24-30.
|
| 42 |
WANG J， YIN J， WANG X， et al. Changing expression profiles of mRNA， lncRNA， circRNA， and miRNA in lung tissue reveal the pathophysiological of bronchopulmonary dysplasia （BPD） in mouse model［J］. J Cell Biochem， 2019， 120（6）： 9369-9380.
|
| 43 |
ZHANG Y， COARFA C， DONG X， et al. MicroRNA-30a as a candidate underlying sex-specific differences in neonatal hyperoxic lung injury： implications for BPD［J］. Am J Physiol Lung Cell Mol Physiol， 2019， 316（1）： L144-L156.
|
| 44 |
SYED M， DAS P， PAWAR A， et al. Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs［J］. Nat Commun， 2017， 8（1）： 1173.
|
| 45 |
YUAN H S， XIONG D Q， HUANG F， et al. MicroRNA-421 inhibition alleviates bronchopulmonary dysplasia in a mouse model via targeting Fgf10［J］. J Cell Biochem， 2019， 120（10）： 16876-16887.
|
| 46 |
KOPP F， MENDELL J T. Functional classification and experimental dissection of long noncoding RNAs［J］. Cell， 2018， 172（3）： 393-407.
|
| 47 |
QIAN X Y， ZHAO J Y， YEUNG P Y， et al. Revealing lncRNA structures and interactions by sequencing-based approaches［J］. Trends Biochem Sci， 2019， 44（1）： 33-52.
|
| 48 |
CHARLES RICHARD J L， EICHHORN P J A. Platforms for investigating LncRNA functions［J］. SLAS Technol，2018， 23（6）： 493-506.
|
| 49 |
CAI C， QIU J J， QIU G， et al. Long non-coding RNA MALAT1 protects preterm infants with bronchopulmonary dysplasia by inhibiting cell apoptosis［J］. BMC Pulm Med， 2017， 17（1）： 1-8.
|
| 50 |
张 艳， 包天平， 宋晓彤， 等. 长链非编码RNA_AK096792作为早产儿支气管肺发育不良早期诊断的脐带血清标志物研究［J］. 中华实用儿科临床杂志， 2018， 33（14）： 1075-1078.
|
| 51 |
BAO T P， WU R， CHENG H P， et al. Differential expression of long non-coding RNAs in hyperoxia-induced bronchopulmonary dysplasia［J］. Cell Biochem Funct， 2016， 34（5）： 299-309.
|
| 52 |
包天平， 田兆方， 赵 赛， 等. 长链非编码RNA1010001N08Rik在支气管肺发育不良形成中的表达规律及生物信息学分析［J］. 中华新生儿科杂志（中英文）， 2017， 32（5）： 384-388.
|
